SIOUX FALLS, S.D. (KELO) —A Garretson family is doing what it can to raise money to find a cure for a rare syndrome. Three-year-old Carter Dreckman was diagnosed with CTNNB1 when he was just 10 months ...
Impact of CTNNB1 alterations on outcomes in patients with hepatocellular carcinoma (HCC). Efficacy and safety of envafolimab plus lenvatinib combined with TACE in initially unresectable hepatocellular ...
A retrospective analysis of 1,804 patients with NSCLC undergoing next-generation sequencing (NGS) in 2019-2024 at University Hospital Würzburg (single-center cohort, including 15 patients with ...
(A) Design of 10 crRNAs matching Ctnnb1 or Smo transcripts. (B) Schematic of Ctnnb1 or Smo knockdown by CRISPR/CasRx. The sequences of the crRNA spacer are complementary to the Ctnnb1 or Smo ...
Patients with CTNNB1 Syndrome will benefit from this joint effort to develop and manufacture a new AAV investigational gene therapy, which aims to restore gene function and may improve quality of life ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...
Loss-of-function mutations in the CTNNB1 gene cause β-catenin deficiency, leading to CTNNB1 syndrome, a rare neurodevelopmental disorder marked by motor and cognitive impairments. Because the disease ...
CTNNB1 syndrome is a neurodevelopmental disorder characterized by intellectual disability, global developmental delay, microcephaly and motor disabilities, among others, caused by pathogenic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback